LSD, mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility
- 1 November 1981
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 75 (4) , 289-296
- https://doi.org/10.1016/0014-2999(81)90556-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Both indoleamine and phenylethylamine hallucinogens increase serotonin in both dorsal and median raphe neuronsLife Sciences, 1980
- Psychotomimetics potentiate locomotor hyperactivity induced by dopaminergic drugsPharmacology Biochemistry and Behavior, 1979
- Neuroleptic interaction with the serotoninergic-dopaminergic mechanisms in the nucleus accumbensJournal of Pharmacy and Pharmacology, 1978
- Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviourLife Sciences, 1978
- Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brainEuropean Journal of Pharmacology, 1977
- Serotoninergic modulation of the dopamine response from the nucleus accumbensJournal of Pharmacy and Pharmacology, 1976
- Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathwaysBrain Research, 1976
- Brain stem and spinal cord mediation of a serotonergic behavioral syndromeBrain Research, 1975
- Is there a catecholamine-serotonin interaction in the control of locomotor activity?Neuropharmacology, 1975
- D-LSD binding to brain homogenates: Possible relationship to serotonin receptorsLife Sciences, 1974